Thread · #other-peptides · 2025-04-19

one at a time, baseline first, assay the lot

Spun off from a message in #other-peptides on 2025-04-19. 12 messages, 4 participants.

The message this came from

plateau_pen — evidence check one at a time, baseline first, assay the lot, write it down. that is the entire method and it is not sophisticated, not a clinician 11:04

interested not confident

🧊14💀6

sort of, standards are the limit

🔥14📉13

came back after 8 months off and my baseline was where it was before, so nothing persisted, happy to be shown a real paper

📈13

noting for later i stacked three things for 4 months and the honest conclusion is that i learned nothing, not a clinician

ill take your word, counterion is a bigger share

nobody knows honestly

no human data

thanks thats useful, one thing at a time

counterion matters more on the short peptides because the counterion mass fraction is a bigger share, that is preclinical, not human data

the honest state of most of this is that we do not know, and the room is unusually good at saying so, evidence standards are strict here

😂1

log the nothings

disagree but ok, thats a deletion sequence